Patients presenting with primary aldosteronism experience more cardiovascular events than
patients with essential hypertension independent of blood pressure. Therefore, the presence …

After the first cases of primary aldosteronism were described and characterized by Conn, a
substantial body of experimental and clinical evidence about the long-term effects of excess …

Over six decades since primary aldosteronism was first described, much has been learned
about its prevalence and optimal treatment. Estimates of the prevalence of primary …

Background: Hypertension is one of the world's leading risk factors for morbidity and
mortality. Most affected individuals have primary hypertension, while the most common …

Primary aldosteronism is now thought to be the commonest potentially curable and
specifically treatable form of hypertension. The detection of primary aldosteronism is of …

Primary aldosteronism used to be considered a rare cause of secondary hypertension.
However, accruing evidence indicates that primary aldosteronism is more common than …

Primary aldosteronism is a frequent form of secondary hypertension that had long been
considered relatively benign. Experimental and clinical evidence collected in the last two …

Primary aldosteronism is a prevalent but underdiagnosed cause of hypertension,
contributing to increased cardiovascular and cerebrovascular events and end-organ …

Background: Aldosterone plays a detrimental role on the cardiovascular system and PA
patients display a higher risk of events compared with EH. Objectives: The objectives of the …

The identification of primary aldosteronism as a common cause of resistant hypertension is a
significant advance in our ability to care for patients with hypertension. Primary …